← Back to Search

Radiofrequency Device

Radio Frequency Treatment for Acne

N/A
Waitlist Available
Led By Anna M Chapas, MD
Research Sponsored by InMode MD Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects with mild to severe Acne Vulgaris, defined as a baseline IGA (Investigator's Global Assessment) score of 2, 3 or 4 and 10-100 inflammatory lesions (papules or pustules)
Subject is >16 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights

Study Summary

This trial tests a device to safely and effectively treat acne on the face, from mild to severe.

Who is the study for?
This trial is for individuals over 16 with mild to severe facial acne who are in good health and willing to avoid sun exposure or use sunscreen. They must not be using other acne treatments, changing hormonal contraception, or have had certain procedures like RF treatment in the past 6 months. Those with metal implants, skin cancer history, active infections like herpes in the area, immune disorders, or on anticoagulants can't participate.Check my eligibility
What is being tested?
The trial tests the safety and effectiveness of a Radio Frequency device called Morpheus8 for treating different levels of facial acne vulgaris. Participants will undergo this non-invasive treatment and follow up visits to assess changes in their acne condition without using any other acne therapies during the study.See study design
What are the potential side effects?
While not explicitly listed here, potential side effects may include temporary redness, swelling at the treatment site, discomfort during application, rare risk of burns from heat generated by radiofrequency energy and possible aggravation of existing skin conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have mild to severe acne with 10-100 inflamed spots.
Select...
I am older than 16 years.
Select...
I agree not to start or change my birth control during the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of responder
Secondary outcome measures
Absolute change in non-inflammatory acne lesions
Absolute change in number of inflammatory acne lesions
Percent change in non-inflammatory acne lesions
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device treatmentExperimental Treatment1 Intervention
Treatment area will include affected areas over the entire face (presence of comedones, pustules, papules, nodules and cysts

Find a Location

Who is running the clinical trial?

InMode MD Ltd.Lead Sponsor
23 Previous Clinical Trials
1,323 Total Patients Enrolled
Anna M Chapas, MDPrincipal Investigator
Jole L Cohen, MDPrincipal InvestigatorUnafilliated

Media Library

Morpheus8 Applicator (Radiofrequency Device) Clinical Trial Eligibility Overview. Trial Name: NCT05830968 — N/A
Acne Research Study Groups: Device treatment
Acne Clinical Trial 2023: Morpheus8 Applicator Highlights & Side Effects. Trial Name: NCT05830968 — N/A
Morpheus8 Applicator (Radiofrequency Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05830968 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any volunteers being accepted for this experiment currently?

"According to the clinicaltrials.gov website, this particular medical trial is no longer recruiting patients. Initially published on May 1st 2023 and last updated April 25th of the same year, it has been superseded by 36 other active studies currently seeking participants."

Answered by AI

Who else is applying?

What site did they apply to?
UT Southwestern Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~21 spots leftby May 2025